Promising Treatment to Slow Kidney Disease Doesn’t Prove Out in Clinical Trial

Michael Mauer, MD, professor in the Departments of Pediatrics and Medicine and kidney specialist at the University of Minnesota Medical School, and his colleagues conducted an international, multi-institution, randomized clinical trial that enrolled 530 participants to study whether allopurinol would slow the disease. 


Congratulations to Dr. Mark Rosenberg for receiving the President's Award for Outstanding Service! About the Award

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 ∙ Locally led by Dr. Susan Kline, Professor of Medicine, Division of Infectious Diseases and International Medicine